<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30944243</article-id>
<article-id pub-id-type="pmc">6483652</article-id>
<article-id pub-id-type="publisher-id">122678</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.122678</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>IL-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following Zika virus infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Jun</given-names>
</name>
<email>jlei6@jhmi.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vermillion</surname>
<given-names>Meghan S.</given-names>
</name>
<email>mvermillion@lrri.org</email>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jia</surname>
<given-names>Bei</given-names>
</name>
<email>jiabei201612@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Han</given-names>
</name>
<email>xhhemoglobin@hotmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Li</given-names>
</name>
<email>lixie.nwpu@foxmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McLane</surname>
<given-names>Michael W.</given-names>
</name>
<email>mmclane1@jhmi.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sheffield</surname>
<given-names>Jeanne S.</given-names>
</name>
<email>jsheffi2@jhmi.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3248-1761</contrib-id>
<name>
<surname>Pekosz</surname>
<given-names>Andrew</given-names>
</name>
<email>apekosz@jhsph.edu</email>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4576-9636</contrib-id>
<name>
<surname>Brown</surname>
<given-names>Amanda</given-names>
</name>
<email>abrown76@jhmi.edu</email>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0730-5224</contrib-id>
<name>
<surname>Klein</surname>
<given-names>Sabra L.</given-names>
</name>
<email>sklein2@jhu.edu</email>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Burd</surname>
<given-names>Irina</given-names>
</name>
<email>iburd@jhmi.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Integrated Research Center for Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</aff>
<aff id="A2"><label>2</label>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</aff>
<aff id="A3"><label>3</label>Department of Molecular and Comparative Pathobiology,</aff>
<aff id="A4"><label>4</label>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</aff>
<aff id="A5"><label>5</label>Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Irina Burd, Integrated Research Center for Fetal Medicine and Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Phipps 217, Baltimore, Maryland 21287, USA. Phone: 410.955.8496. Email: <email>Iburd@jhmi.edu</email>. Or to: Sabra L. Klein, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room W2118, Baltimore, Maryland 21205, USA. Phone: 410.955.8898; Email: <email>Sklein2@jhu.edu</email>.</corresp>
<fn>
<p><bold>Authorship note:</bold> JL and MSV contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-02-28T12:00:00-0500" publication-format="electronic">
<day>28</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-04-04T09:00:00-0400" publication-format="electronic">
<day>4</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>2</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>4</volume>
<issue>7</issue>
<elocation-id>e122678</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 American Society for Clinical Investigation</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/122678">This article is available online at https://insight.jci.org/articles/view/122678</self-uri>
<abstract>
<p>Zika virus (ZIKV) infection during pregnancy causes significant adverse sequelae in the developing fetus, and results in long-term structural and neurologic defects. Most preventive and therapeutic efforts have focused on the development of vaccines, antivirals, and antibodies. The placental immunologic response to ZIKV, however, has been largely overlooked as a target for therapeutic intervention. The placental inflammatory response, specifically IL-1β secretion and signaling, is induced by ZIKV infection and represents an environmental factor that is known to increase the risk of perinatal developmental abnormalities. We show in a mouse model that maternally administrated IL-1 receptor antagonist (IRA; Kineret, or anakinra), following ZIKV exposure, can preserve placental function (by improving trophoblast invasion and placental vasculature), increase fetal viability, and reduce neurobehavioral deficits in the offspring. We further demonstrate that while ZIKV RNA is highly detectable in placentas, it is not correlated with fetal viability. Beyond its effects in the placenta, we show that IL-1 blockade may also directly decrease fetal neuroinflammation by mitigating fetal microglial activation in a dose-dependent manner. Our studies distinguish the role of placental inflammation during ZIKV-infected pregnancies, and demonstrate that maternal IRA may attenuate fetal neuroinflammation and improve perinatal outcomes.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Reproductive Biology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Immunotherapy</kwd>
<kwd>Obstetrics/gynecology</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Johns Hopkins University</funding-source>
<award-id>OD011089</award-id>
</award-group>
<award-group>
<funding-source>National Institutes of Health</funding-source>
<award-id>NIH R01HD097608</award-id>
</award-group>
<award-group>
<funding-source>The American Association of Obstetricians and Gynecologists Foundation</funding-source>
<award-id>80028729</award-id>
</award-group>
<funding-statement>This work was supported by the Integrated Research Center for Fetal Medicine (I.B.), Sheikh Abdullah Bugshan Fund (I.B.), the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases (S.K.), and the NIH T32 OD011089 Training Veterinarians for Careers in Biomedical Research (M.V.).</funding-statement>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>